πŸ‡ΊπŸ‡Έ FDA
Patent

US 11661439

Peptide hydrogels and use thereof

granted A61KA61K38/00A61K40/11

Quick answer

US patent 11661439 (Peptide hydrogels and use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 30 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61K, A61K38/00, A61K40/11, A61K40/31, A61K40/42